About (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid
(E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid (PubChem CID 122663359) has the molecular formula C27H27FN6O3
and a molecular weight of 502.55 g/mol. Its IUPAC name is (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid.
Molecular Properties
| Compound Name | (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid |
| PubChem CID | 122663359 |
| Molecular Formula | C27H27FN6O3 |
| Molecular Weight | 502.55 g/mol |
| Exact Mass | 502.21 |
| IUPAC Name | (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid |
| SMILES | C[C@@H]1CCCCCN1C(=O)c1cc(-c2cnn(C)c2)n2nc(-c3ccc(/C=C/C(=O)O)cc3F)cc2n1 |
| InChI | InChI=1S/C27H27FN6O3/c1-17-6-4-3-5-11-33(17)27(37)23-13-24(19-15-29-32(2)16-19)34-25(30-23)14-22(31-34)20-9-7-18(12-21(20)28)8-10-26(35)36/h7-10,12-17H,3-6,11H2,1-2H3,(H,35,36)/b10-8+/t17-/m1/s1 |
| InChIKey | VOYXMDPUYAPOQK-SYJIQKIWSA-N |
| XLogP | 4.44 |
| TPSA | 105.62 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 502.55 |
| LogP ≤ 5 | 4.44 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid?
The IUPAC name of (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid (CID 122663359) is (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid.
What is the SMILES notation for (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid?
The canonical SMILES for (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid is C[C@@H]1CCCCCN1C(=O)c1cc(-c2cnn(C)c2)n2nc(-c3ccc(/C=C/C(=O)O)cc3F)cc2n1.
What is the InChIKey of (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid?
The InChIKey is VOYXMDPUYAPOQK-SYJIQKIWSA-N. The full InChI is InChI=1S/C27H27FN6O3/c1-17-6-4-3-5-11-33(17)27(37)23-13-24(19-15-29-32(2)16-19)34-25(30-23)14-22(31-34)20-9-7-18(12-21(20)28)8-10-26(35)36/h7-10,12-17H,3-6,11H2,1-2H3,(H,35,36)/b10-8+/t17-/m1/s1.
What are the key properties of (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid?
(E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid has a molecular weight of 502.55 g/mol, XLogP of 4.44, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[3-fluoro-4-[5-[(2R)-2-methylazepane-1-carbonyl]-7-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-2-yl]phenyl]prop-2-enoic acid is sourced from PubChem (CID 122663359), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).